1,009
Participants
Start Date
April 30, 2009
Primary Completion Date
October 31, 2009
Study Completion Date
October 31, 2009
Regadenoson
IV
Placebo
IV
Upland
Newark
Wilmington
Raleigh
Spartanburg
Charleston
Greenville
Easley
Stockbridge
DeLand
Winter Park
Miami
Clearwater
Trinity
Montgomery
Knoxville
Chardon
Cincinnati
Cincinnati
Minneapolis
Plymouth
Aurora
St Louis
Topeka
Papillion
Shreveport
Oklahoma City
Dallas
Houston
New Braunfels
San Antonio
Long Beach
Encinitas
San Diego
San Diego
Huntington Beach
Mission Viejo
Santa Ana
Anaheim
Fullerton
Roseville
Medford
Seattle
Waterbury
Auburn
No. Dartmouth
Brick
Providence
Lead Sponsor
Astellas Pharma Inc
INDUSTRY